'The use of acacia gum in end stage renal failure'

Journal of Tropical Pediatrics

Volumn 53, Issue 5, 2007, Pages 362-365

  Al Mosawi, Aamir Jalal ^a  

^a BASRA UNIVERSITY   (Iraq)

Author keywords

Long dialysis freedom; New model management end stage renal failure

Indexed keywords

ANTIEMETIC AGENT; CREATININE; GUM ARABIC; NANDROLONE DECANOATE; PYRIDOXINE; UREA;

ALBUMINURIA; ANOREXIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHRONIC KIDNEY FAILURE; CONSERVATIVE TREATMENT; CREATININE BLOOD LEVEL; DIET THERAPY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; NAUSEA; PARENT; PERITONEAL DIALYSIS; PHYSICAL ACTIVITY; PROTEIN RESTRICTION; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; SYMPTOM; TACHYPNEA; TREATMENT REFUSAL; UREA BLOOD LEVEL; UREMIA; VOMITING; WELLBEING;

CHILD; CHILD DEVELOPMENT; DEVELOPING COUNTRIES; DIET, PROTEIN-RESTRICTED; DIETARY SUPPLEMENTS; FEMALE; GUM ARABIC; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 36249004926     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmm033     Document Type: Article

References (20)

1. Al-Mosawi AJ. Acacia gum therapeutic potential: Possible role in the management of uremia -a new potential medicine. Therapy 2006;3:301-21. www.future-dugs.com.
2. Harmon WE. Chronic renal failure, overview of chronic renal failure. In: Barrat TM, Avner ED, Harmon WE (eds). Pediatric Nephrology. 4th edn, Baltimore: Lippincott Williams and Wilkins, 1999, 1151-4.
3. Al-Mosawi AJ. Acacia gum supplementation of a low-protein diet in children with end-stage renal disease. Pediatr Nephrol 2004;19:1156-9.
4. Al Mosawi AJ. Continuous renal replacement in the developing world: Is there any alternative. Therapy (London) 2006;3:265 72. www.future-dugs.com.
5. Chesney RW, Patters A. Acacia gum in chronic renal failure. Therapy 2006;3:183-5. www.future-dugs.com.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
7. Insley J, Wood BA. edn. Pediatric Vade Mecum. 10th edn, London, UK: Lloyd-Luke Ltd, 1982, 16.
8. Bliss DZ, Stein TP, Schleifer CR, et al. Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen excretion in chronic renal failure patients consuming a low protein diet. Am J Clin Nutr 1996;63:392-8.
9. Al-Mosawi AJ. The challenge of chronic renal failure in the developing world: Possible use of acacia gum. Pediatr Nephrol 2002;17:390-1.
10. Vimalachandra D, Caig JC, Cowel C, et al. Growth hormone for children with chronic renal failure. Cochrane Database Syst Rev 2001; CDO03264.
11. Al-Mosawi AJ. Experience with refractory vitamin D-resistant rickets and non-17α alkyl testosterone derivative anabolic agent. Therapy (London) 2005;2:91-4. www.future-dugs.com.
12. Silver HK, Peterson RG, Rumack BH. Drug therapy. In: Kempe CH, Silver HK, O'Brien D, et al. (eds). Current Pediatric Diagnosis & Treatment,. 9th edn, CT, USA: Appleton & Lang, 1987, 1093-05.
13. Jones RW, El Bishti MM, Bloom SR, et al. The effects of anabolic steroids on growth, body composition and metabolism in boys with chronic renal failure on regular hemodialysis. J Pediatr 1980;97:559-66.
14. Barton Pai A, Chretien C, Lau AH. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients. Clin Nephrol 2002;58:38-46.
15. Gaughan WL Liss KA, Dunn SR, et al. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis 1997;30:495-500.
16. Ballal SH, Domoto DT, Polack DC, et al. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease. Am J Kidney Dis 1991;17:29-33.
17. Lee MS, Ahn SH, Song JH. Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin. Korean J Intern Med 2002;17:167-73.
18. Doane BD, Fried W, Schwartz F. Response of uremic patients to nandrolone decanoate. Arch Intern Med 1975;135:972-5.
19. Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: A randomized controlled trial. JAMA 1999;281:1275-81.
20. US Food and Drug Administration GRAS (generally recommended as safe) food ingredient gum arabic. Washington, US Department of commerce. 1972 (NT/Sno PB 223-614).